Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of ADESHWAR MEDITEX. For more details, see the ADESHWAR MEDITEX quarterly results and ADESHWAR MEDITEX share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -3.2 |
No. of shares | m | 14.43 |
1 Week | % | 0.0 |
1 Month | % | 0.0 |
1 Year | % | - |
52 week H/L | Rs | 36.0/17.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ADESHWAR MEDITEX EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | 42 | 33 | |
Low | Rs | NA | NA | NA | 25 | 17 | |
Sales per share (Unadj.) | Rs | 106.3 | 106.5 | 62.7 | 44.9 | 57.1 | |
Earnings per share (Unadj.) | Rs | 4.5 | 4.0 | 1.6 | 0.5 | 1.4 | |
Diluted earnings per share | Rs | 1.6 | 1.5 | 1.2 | 0.5 | 1.4 | |
Cash flow per share (Unadj.) | Rs | 5.2 | 4.7 | 1.9 | 0.8 | 1.8 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 31.7 | 35.9 | 19.5 | 21.5 | 22.8 | |
Adj. book value per share | Rs | 10.9 | 13.1 | 14.3 | 21.4 | 22.8 | |
Shares outstanding (eoy) | m | 4.98 | 5.27 | 10.53 | 14.43 | 14.43 | |
Price / Sales ratio | x | 0 | 0 | 0 | 0.7 | 0.4 | |
Avg P/E ratio | x | 0 | 0 | 0 | 61.0 | 17.3 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 41.1 | 13.8 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 1.6 | 1.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 483 | 359 | |
Total wages/salary | Rs m | 23 | 12 | 15 | 13 | 13 |
ADESHWAR MEDITEX INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 529 | 561 | 660 | 648 | 824 | |
Other income | Rs m | 18 | 3 | 3 | 2 | 3 | |
Total revenues | Rs m | 547 | 564 | 662 | 650 | 827 | |
Gross profit | Rs m | 39 | 55 | 47 | 34 | 52 | |
Depreciation | Rs m | 4 | 3 | 3 | 4 | 5 | |
Interest | Rs m | 22 | 25 | 23 | 21 | 21 | |
Profit before tax | Rs m | 31 | 29 | 23 | 12 | 29 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 9 | 8 | 7 | 4 | 8 | |
Profit after tax | Rs m | 23 | 21 | 17 | 8 | 21 | |
Gross profit margin | % | 7.3 | 9.8 | 7.1 | 5.2 | 6.3 | |
Effective tax rate | % | 27.9 | 27.2 | 28.3 | 33.4 | 28.6 | |
Net profit margin | % | 4.3 | 3.8 | 2.5 | 1.2 | 2.5 |
ADESHWAR MEDITEX BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 393 | 500 | 571 | 651 | 596 | |
Current liabilities | Rs m | 223 | 292 | 358 | 371 | 314 | |
Net working cap to sales | % | 32.1 | 37.1 | 32.2 | 43.3 | 34.3 | |
Current ratio | x | 1.8 | 1.7 | 1.6 | 1.8 | 1.9 | |
Inventory Days | Days | 14 | 16 | 16 | 24 | 16 | |
Debtors Days | Days | 1,354 | 181,301,403 | 1,508 | 1,831 | 1,238 | |
Net fixed assets | Rs m | 45 | 47 | 51 | 73 | 73 | |
Share capital | Rs m | 50 | 53 | 105 | 144 | 144 | |
"Free" reserves | Rs m | 108 | 136 | 101 | 165 | 185 | |
Net worth | Rs m | 158 | 189 | 206 | 310 | 329 | |
Long term debt | Rs m | 50 | 61 | 54 | 41 | 23 | |
Total assets | Rs m | 438 | 547 | 622 | 724 | 669 | |
Interest coverage | x | 2.4 | 2.2 | 2.0 | 1.6 | 2.4 | |
Debt to equity ratio | x | 0.3 | 0.3 | 0.3 | 0.1 | 0.1 | |
Sales to assets ratio | x | 1.2 | 1.0 | 1.1 | 0.9 | 1.2 | |
Return on assets | % | 10.2 | 8.5 | 6.4 | 3.9 | 6.2 | |
Return on equity | % | 14.2 | 11.2 | 8.1 | 2.6 | 6.3 | |
Return on capital | % | 25.7 | 21.7 | 17.9 | 9.3 | 14.2 | |
Exports to sales | % | 11.0 | 7.0 | 9.8 | 4.7 | 6.1 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 58 | 39 | 64 | 31 | 50 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 59 | 39 | 64 | 31 | 50 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 59 | 39 | 64 | 31 | 50 |
ADESHWAR MEDITEX CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -59 | -10 | 32 | -24 | 59 | |
From Investments | Rs m | -3 | 16 | -7 | -12 | -12 | |
From Financial Activity | Rs m | 62 | -1 | -31 | 44 | -48 | |
Net Cashflow | Rs m | 0 | 5 | -7 | 9 | -0 |
Share Holding
Shareholding as on Sep 2023
|
Company Information
|
CHM: Siddharth Mulchand Talati | COMP SEC: Shivani Tiwari | YEAR OF INC: 2007 | BSE CODE: 543309 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ADESHWAR MEDITEX With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.